Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 Apr;53(4):394–399. doi: 10.1136/hrt.53.4.394

Cellular immunity in congestive cardiomyopathy. The normal cellular immune response.

P J Lowry, R A Thompson, W A Littler
PMCID: PMC481779  PMID: 3157395

Abstract

In vivo and in vitro tests of cellular immunity were studied in patients with congestive cardiomyopathy to determine whether these patients have normal or depressed cell mediated immunity to common environmental antigens and mitogens. No abnormality was found, but this does not exclude the possibility that transient depression of cell mediated mechanisms occurs early in the illness before clinical presentation.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates S. E., Suen J. Y., Tranum B. L. Immunological skin testing and interpretation: a plea for uniformity. Cancer. 1979 Jun;43(6):2306–2314. doi: 10.1002/1097-0142(197906)43:6<2306::aid-cncr2820430621>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  2. Cambridge G., MacArthur C. G., Waterson A. P., Goodwin J. F., Oakley C. M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Das S. K., Stein L. D., Thebert P. J., Reynolds R. T., Cassidy J. T. Inhibition of leucocyte migration by stimulated mononuclear cell supernatants from patients with ischaemic heart disease. Br Heart J. 1983 Apr;49(4):381–387. doi: 10.1136/hrt.49.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. David J. R., David R. R. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy. 1972;16:300–449. [PubMed] [Google Scholar]
  5. Dumonde D. C., Wolstencroft R. A., Panayi G. S., Matthew M., Morley J., Howson W. T. "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969 Oct 4;224(5214):38–42. doi: 10.1038/224038a0. [DOI] [PubMed] [Google Scholar]
  6. Eckstein R., Mempel W., Bolte H. D. Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation. 1982 Jun;65(6):1224–1229. doi: 10.1161/01.cir.65.6.1224. [DOI] [PubMed] [Google Scholar]
  7. FARNES P., BARKER B. E., BROWNHILL L. E., FANGER H. MITOGENIC ACTIVITY IN PHYTOLACCA AMERICANA (POKEWEED). Lancet. 1964 Nov 21;2(7369):1100–1101. doi: 10.1016/s0140-6736(64)92616-9. [DOI] [PubMed] [Google Scholar]
  8. Fletcher G. F., Wenger N. K. Autoimmune studies in patients with primary myocardial disease. Circulation. 1968 Jun;37(6):1032–1035. doi: 10.1161/01.cir.37.6.1032. [DOI] [PubMed] [Google Scholar]
  9. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  10. Goodwin J. F., Oakley C. M. The cardiomyopathies. Br Heart J. 1972 Jun;34(6):545–552. doi: 10.1136/hrt.34.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goodwin J. F. The frontiers of cardiomyopathy. Br Heart J. 1982 Jul;48(1):1–18. doi: 10.1136/hrt.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Górski A. J. Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay. Clin Exp Immunol. 1974 Sep;18(1):149–153. [PMC free article] [PubMed] [Google Scholar]
  13. Jacobs B., Matsuda Y., Deodhar S., Shirey E. Cell-mediated cytotoxicity to cardiac cells of lymphocytes from patients with primary myocardial disease. Am J Clin Pathol. 1979 Jul;72(1):1–4. doi: 10.1093/ajcp/72.1.1. [DOI] [PubMed] [Google Scholar]
  14. Kawai C. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J. 1971 Jul;35(7):765–770. doi: 10.1253/jcj.35.765. [DOI] [PubMed] [Google Scholar]
  15. Kawai C., Takatsu T. Clinical and experimental studies on cardiomyopathy. N Engl J Med. 1975 Sep 18;293(12):592–597. doi: 10.1056/NEJM197509182931207. [DOI] [PubMed] [Google Scholar]
  16. Lowry P. J., Thompson R. A., Littler W. A. Humoral immunity in cardiomyopathy. Br Heart J. 1983 Oct;50(4):390–394. doi: 10.1136/hrt.50.4.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. NOWELL P. C. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 1960 May;20:462–466. [PubMed] [Google Scholar]
  18. Palmer D. L., Reed W. P. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis. 1974 Aug;130(2):132–137. doi: 10.1093/infdis/130.2.132. [DOI] [PubMed] [Google Scholar]
  19. Rocklin R. E., Meyers O. L., David J. R. An in vitro assay for cellular hypersensitivity in man. J Immunol. 1970 Jan;104(1):95–102. [PubMed] [Google Scholar]
  20. Rocklin R. E. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol. 1974 Apr;112(4):1461–1466. [PubMed] [Google Scholar]
  21. Sachs R. N., Lanfranchi J. Cardiomyopathies primitives et anomalies immunitaires. Coeur Med Interne. 1978 Apr-Jun;17(2):193–198. [PubMed] [Google Scholar]
  22. Stefani S., Kerman R., Abbate J. Immune evaluation of lung cancer patients undergoing radiation therapy. Cancer. 1976 Jun;37(6):2792–2796. doi: 10.1002/1097-0142(197606)37:6<2792::aid-cncr2820370634>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  23. Thompson C. D., Whittingham S., Mackay I. R., Khoo S. K., Toh B. H., Stagg R. J. Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens. Can Med Assoc J. 1975 May 3;112(9):1078–1081. [PMC free article] [PubMed] [Google Scholar]
  24. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol. 1969 May;55(2):253–265. [PMC free article] [PubMed] [Google Scholar]
  25. Woodruff J. F., Woodruff J. J. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol. 1974 Dec;113(6):1726–1734. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES